US Stock MarketDetailed Quotes

Repare Therapeutics (RPTX)

Watchlist
  • 2.590
  • 0.0000.00%
Close Jan 22 16:00 ET
111.65MMarket Cap-1.52P/E (TTM)

Repare Therapeutics (RPTX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
108.68%2.65M
46.44%-16.34M
-344.16%-29.13M
39.88%-76.45M
2.95%-27.32M
7.09%-30.54M
11.16%-30.51M
137.54%11.93M
-39,590.06%-127.16M
5.00%-28.16M
Net income from continuing operations
109.47%3.26M
51.85%-16.74M
-328.26%-30.04M
9.71%-84.69M
-2.29%-28.67M
-82.24%-34.41M
-191.09%-34.77M
137.67%13.16M
-222.91%-93.8M
11.46%-28.03M
Operating gains losses
-1,037.50%-91K
-115,520.00%-5.78M
90.91%-2K
-89.74%8K
514.29%43K
-172.73%-8K
16.67%-5K
-133.33%-22K
126.17%78K
110.29%7K
Depreciation and amortization
-84.94%72K
112.30%1.04M
136.73%1.19M
-1.54%1.92M
-10.28%454K
-4.02%478K
-3.56%488K
13.61%501K
-1.37%1.95M
11.21%506K
Other non cash items
-1,015.32%-6.22M
602.99%3.99M
-0.71%559K
7.52%2.36M
-1.44%549K
23.23%679K
4.22%568K
4.07%563K
-0.54%2.19M
-1.07%557K
Change In working capital
483.16%4.37M
72.98%-445K
43.02%-4.28M
74.53%-14.06M
36.12%-3.77M
94.17%-1.14M
94.04%-1.65M
-254.54%-7.5M
-787.64%-55.18M
8.17%-5.9M
-Change in receivables
241.39%854K
32.73%146K
-69.54%530K
1,357.41%2.72M
289.68%1.47M
-113.31%-604K
108.89%110K
163.48%1.74M
84.40%-216K
-108.23%-775K
-Change in prepaid assets
-8.34%-1.05M
166.67%1.54M
14.00%1.47M
-230.34%-1.26M
-8.73%732K
28.13%-971K
-1,328.72%-2.31M
-3.31%1.29M
63.41%969K
1,066.27%802K
-Change in payables and accrued expense
-679.90%-4.89M
-162.44%-1.38M
-797.87%-5.89M
-168.87%-2.99M
-902.96%-5.42M
15.38%-627K
-25.91%2.21M
-40.94%844K
81.92%4.35M
130.21%675K
-Change in other current assets
--0
--0
101.12%179K
114.85%217K
1,200.00%13K
945.45%115K
--0
0.00%89K
13.48%101K
--1K
-Change in other current liabilities
48.11%-302K
-28.60%-751K
3.78%-560K
-4.01%-2.31M
0.88%-563K
-5.05%-582K
-5.42%-584K
-6.59%-582K
-45.13%-2.22M
-43.80%-568K
-Change in other working capital
----
----
----
82.08%-10.42M
--0
107.13%1.53M
96.30%-1.07M
-548.72%-10.88M
-839.02%-58.16M
54.02%-6.03M
Cash from discontinued investing activities
Operating cash flow
108.68%2.65M
46.44%-16.34M
-344.16%-29.13M
39.88%-76.45M
2.95%-27.32M
7.09%-30.54M
11.16%-30.51M
137.54%11.93M
-39,590.06%-127.16M
5.00%-28.16M
Investing cash flow
Cash flow from continuing investing activities
-91.84%2.54M
-108.23%-586K
241.72%28.79M
-36.61%49.47M
-0.92%31.59M
26.87%31.08M
-74.89%7.12M
-203.86%-20.32M
144.40%78.04M
-6.40%31.88M
Net PPE purchase and sale
----
----
----
--0
--0
--0
--0
--0
-221.93%-1.94M
-123.14%-398K
Net intangibles purchase and sale
--0
----
----
----
----
--0
----
----
----
----
Net investment purchase and sale
-91.84%2.54M
-122.28%-1.59M
241.72%28.79M
-38.15%49.47M
-2.14%31.59M
26.87%31.08M
-75.80%7.12M
-227.10%-20.32M
145.66%79.98M
-0.19%32.28M
Cash from discontinued investing activities
Investing cash flow
-91.84%2.54M
-108.23%-586K
241.72%28.79M
-36.61%49.47M
-0.92%31.59M
26.87%31.08M
-74.89%7.12M
-203.86%-20.32M
144.40%78.04M
-6.40%31.88M
Financing cash flow
Cash flow from continuing financing activities
-81.93%30K
0
-78.93%79K
-35.63%542K
-99.05%1K
-41.55%166K
0
-9.20%375K
-4.32%842K
-36.36%105K
Proceeds from stock option exercised by employees
-81.93%30K
--0
-78.93%79K
-35.63%542K
-99.05%1K
-41.55%166K
--0
-9.20%375K
-4.32%842K
-36.36%105K
Cash from discontinued financing activities
Financing cash flow
-81.93%30K
--0
-78.93%79K
-35.63%542K
-99.05%1K
-41.55%166K
--0
-9.20%375K
-4.32%842K
-36.36%105K
Net cash flow
Beginning cash position
-15.24%67.66M
-18.18%84.46M
-23.86%84.72M
-30.25%111.27M
-24.99%80.54M
-30.92%79.82M
-15.02%103.22M
-30.25%111.27M
-52.30%159.52M
-30.81%107.37M
Current changes in cash
638.05%5.22M
27.65%-16.93M
96.73%-262K
45.24%-26.44M
11.36%4.26M
108.74%707K
-292.81%-23.4M
78.96%-8.01M
72.35%-48.28M
-16.53%3.83M
Effect of exchange rate changes
-450.00%-49K
13,000.00%129K
--0
-627.27%-116K
-222.54%-87K
116.09%14K
-102.56%-1K
-4,100.00%-42K
106.67%22K
127.73%71K
End cash Position
-9.58%72.83M
-15.24%67.66M
-18.18%84.46M
-23.86%84.72M
-23.86%84.72M
-24.99%80.54M
-30.92%79.82M
-15.02%103.22M
-30.25%111.27M
-30.25%111.27M
Free cash flow
108.68%2.65M
46.44%-16.34M
-344.16%-29.13M
40.78%-76.45M
4.31%-27.32M
7.09%-30.54M
13.83%-30.51M
136.99%11.93M
-46,005.71%-129.1M
-2.28%-28.55M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 108.68%2.65M46.44%-16.34M-344.16%-29.13M39.88%-76.45M2.95%-27.32M7.09%-30.54M11.16%-30.51M137.54%11.93M-39,590.06%-127.16M5.00%-28.16M
Net income from continuing operations 109.47%3.26M51.85%-16.74M-328.26%-30.04M9.71%-84.69M-2.29%-28.67M-82.24%-34.41M-191.09%-34.77M137.67%13.16M-222.91%-93.8M11.46%-28.03M
Operating gains losses -1,037.50%-91K-115,520.00%-5.78M90.91%-2K-89.74%8K514.29%43K-172.73%-8K16.67%-5K-133.33%-22K126.17%78K110.29%7K
Depreciation and amortization -84.94%72K112.30%1.04M136.73%1.19M-1.54%1.92M-10.28%454K-4.02%478K-3.56%488K13.61%501K-1.37%1.95M11.21%506K
Other non cash items -1,015.32%-6.22M602.99%3.99M-0.71%559K7.52%2.36M-1.44%549K23.23%679K4.22%568K4.07%563K-0.54%2.19M-1.07%557K
Change In working capital 483.16%4.37M72.98%-445K43.02%-4.28M74.53%-14.06M36.12%-3.77M94.17%-1.14M94.04%-1.65M-254.54%-7.5M-787.64%-55.18M8.17%-5.9M
-Change in receivables 241.39%854K32.73%146K-69.54%530K1,357.41%2.72M289.68%1.47M-113.31%-604K108.89%110K163.48%1.74M84.40%-216K-108.23%-775K
-Change in prepaid assets -8.34%-1.05M166.67%1.54M14.00%1.47M-230.34%-1.26M-8.73%732K28.13%-971K-1,328.72%-2.31M-3.31%1.29M63.41%969K1,066.27%802K
-Change in payables and accrued expense -679.90%-4.89M-162.44%-1.38M-797.87%-5.89M-168.87%-2.99M-902.96%-5.42M15.38%-627K-25.91%2.21M-40.94%844K81.92%4.35M130.21%675K
-Change in other current assets --0--0101.12%179K114.85%217K1,200.00%13K945.45%115K--00.00%89K13.48%101K--1K
-Change in other current liabilities 48.11%-302K-28.60%-751K3.78%-560K-4.01%-2.31M0.88%-563K-5.05%-582K-5.42%-584K-6.59%-582K-45.13%-2.22M-43.80%-568K
-Change in other working capital ------------82.08%-10.42M--0107.13%1.53M96.30%-1.07M-548.72%-10.88M-839.02%-58.16M54.02%-6.03M
Cash from discontinued investing activities
Operating cash flow 108.68%2.65M46.44%-16.34M-344.16%-29.13M39.88%-76.45M2.95%-27.32M7.09%-30.54M11.16%-30.51M137.54%11.93M-39,590.06%-127.16M5.00%-28.16M
Investing cash flow
Cash flow from continuing investing activities -91.84%2.54M-108.23%-586K241.72%28.79M-36.61%49.47M-0.92%31.59M26.87%31.08M-74.89%7.12M-203.86%-20.32M144.40%78.04M-6.40%31.88M
Net PPE purchase and sale --------------0--0--0--0--0-221.93%-1.94M-123.14%-398K
Net intangibles purchase and sale --0------------------0----------------
Net investment purchase and sale -91.84%2.54M-122.28%-1.59M241.72%28.79M-38.15%49.47M-2.14%31.59M26.87%31.08M-75.80%7.12M-227.10%-20.32M145.66%79.98M-0.19%32.28M
Cash from discontinued investing activities
Investing cash flow -91.84%2.54M-108.23%-586K241.72%28.79M-36.61%49.47M-0.92%31.59M26.87%31.08M-74.89%7.12M-203.86%-20.32M144.40%78.04M-6.40%31.88M
Financing cash flow
Cash flow from continuing financing activities -81.93%30K0-78.93%79K-35.63%542K-99.05%1K-41.55%166K0-9.20%375K-4.32%842K-36.36%105K
Proceeds from stock option exercised by employees -81.93%30K--0-78.93%79K-35.63%542K-99.05%1K-41.55%166K--0-9.20%375K-4.32%842K-36.36%105K
Cash from discontinued financing activities
Financing cash flow -81.93%30K--0-78.93%79K-35.63%542K-99.05%1K-41.55%166K--0-9.20%375K-4.32%842K-36.36%105K
Net cash flow
Beginning cash position -15.24%67.66M-18.18%84.46M-23.86%84.72M-30.25%111.27M-24.99%80.54M-30.92%79.82M-15.02%103.22M-30.25%111.27M-52.30%159.52M-30.81%107.37M
Current changes in cash 638.05%5.22M27.65%-16.93M96.73%-262K45.24%-26.44M11.36%4.26M108.74%707K-292.81%-23.4M78.96%-8.01M72.35%-48.28M-16.53%3.83M
Effect of exchange rate changes -450.00%-49K13,000.00%129K--0-627.27%-116K-222.54%-87K116.09%14K-102.56%-1K-4,100.00%-42K106.67%22K127.73%71K
End cash Position -9.58%72.83M-15.24%67.66M-18.18%84.46M-23.86%84.72M-23.86%84.72M-24.99%80.54M-30.92%79.82M-15.02%103.22M-30.25%111.27M-30.25%111.27M
Free cash flow 108.68%2.65M46.44%-16.34M-344.16%-29.13M40.78%-76.45M4.31%-27.32M7.09%-30.54M13.83%-30.51M136.99%11.93M-46,005.71%-129.1M-2.28%-28.55M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More